XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SHAREHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
Schedule of option activity
   
Number of options
   
Weighted average exercise
price
   
Weighted average remaining contractual life
   
Aggregate intrinsic
value
 
         
$
   
Years
   
$
 
                             
Options outstanding at beginning of year
   
8,373,745
     
4.65
     
6.61
     
1,912
 
Options granted
   
40,500
     
2.08
                 
Options exercised
   
(1,744
)
   
0.84
                 
Options forfeited
   
(282,455
)
   
4.55
                 
Options expired
   
(140,000
)
   
8.08
                 
                                 
Options outstanding at end of year
   
7,990,046
     
4.58
     
6.19
     
1,205
 
                                 
Exercisable at end of year
   
5,245,345
     
5.68
     
4.99
     
124
 
Schedule of weighted-average assumptions used to estimate fair value of options granted
   
Six months ended
June 30,
 
   
2024
   
2023
 
   
Unaudited
 
             
Volatility
   
92.7%-95.9
%
   
75.9%-76.4
%
Risk-free interest rate
   
3.9%-4.5
%
   
3.3%-4.2
%
Dividend yield
   
0
%
   
0
%
Expected life (years)
   
4.02
     
5.0-5.1
 
Schedule of stock-based compensation expenses
   
Six months ended
June 30,
 
   
2024
   
2023
 
   
Unaudited
 
             
Research and development expenses
 
$
805
   
$
1,002
 
Marketing and business development expenses
   
43
     
(41
)
General and administrative expenses
   
785
     
821
 
                 
Financial and other income, net
 
$
1,633
   
$
1,782